Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
John Kaldor is Professor of Epidemiology and Deputy Director at Australia's National Centre in HIV Epidemiology and Clinical Research, based at the University of New South Wales in Sydney.
He holds a doctorate in biostatistics from the University of California, Berkeley, USA, and began his research career at the International Agency for Research on Cancer in Lyon, France. For the past 18 years he has built and led an internationally recognised research program on the epidemiology and prevention of HIV infection and other sexually transmitted and blood-borne infections.
Dr Kaldor's interests have included the development and implementation of public health surveillance systems, investigations of HIV-related cancer, cohort and cross-sectional investigations of risk factors for infectious disease transmission, and interventional trials of potential biomedical prevention agents.
Dr Kaldor has taught epidemiology at postgraduate level for over two decades, and regularly contributes to a range of academic meetings and workshops. He is a past president of the Australasian Epidemiological Association, has served on the Governing Council of the International AIDS Society and has been involved as an author in over 340 peer-reviewed scientific publications.
Melissa Robbiani is an immunologist with a particular interest in HIV transmission, pathogenesis, and prevention. She is a Senior Scientist and Director of Biomedical HIV Research at the Population Council and an adjunct faculty of the Rockefeller University, New York, USA. Melissa received her PhD in immunology in 1992 from The University of Adelaide, Australia, before beginning research on dendritic cells and HIV biology at the Rockefeller University. After moving to the Population Council in 2001, Melissa has further expanded her interests to the advancement of microbicide prevention strategies. Her work continues to focus on dissecting the role of dendritic cells in HIV/SIV spread and pathogenesis, in order to identify promising anti-viral strategies through in-vitro and in-vivo macaque studies.